M&A M&A
Cipla acquires South Africa's Actor Pharma for $49-M
Source BSE Announcement (opens in a new tab)Press Release (opens in a new tab)
Listed pharmaceutical company Cipla has acquired 100% stake in South Africa-based Actor Pharma for USD 48.6 million..
Founded in 2009, Actor is the fifth largest privately owned OTC player in the South African market. Actor specialises in OTC and generic medicines in the categories of women's health, nasal, cough & cold, and baby & child. For FY23, Actor had reported revenue of ZAR 233.6 million (USD 12.6 million) as against ZAR 199.3 million (USD 10.8 million) in FY22.